Eric G. Devine, PhD

Assistant Professor, Psychiatry

(617) 638-7888
720 Harrison Ave

Biography

Expertise includes: Treatment research; Clinical trials, State-of-art psychotherapy for addiction; Treatment development and training.

Other Positions

  • Active Staff Hospital Privileges, Psychiatry, Boston Medical Center

Education

  • Bowling Green State University, PhD
  • Bowling Green State University, MA
  • University of Wisconsin–Milwaukee, BA

Publications

  • Published on 8/10/2016

    Devine EG, Ryan ML, Falk DE, Fertig JB, Litten RZ. An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorder. Contemp Clin Trials. 2016 Sep; 50:178-85. PMID: 27521807.

    Read at: PubMed
  • Published on 2/1/2015

    Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, Oscar-Berman M, Surprise C, Colaneri L, Putnam M, Waters M, Richambault C. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders. J Clin Psychopharmacol. 2015 Feb; 35(1):34-42. PMID: 25427171.

    Read at: PubMed
  • Published on 12/18/2014

    Devine EG, Knapp CM, Sarid-Segal O, O'Keefe SM, Wardell C, Baskett M, Pecchia A, Ferrell K, Ciraulo DA. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemp Clin Trials. 2015 Mar; 41:55-61. PMID: 25530307.

    Read at: PubMed
  • Published on 12/18/2014

    Devine, E. G., Knapp CM, Sarid-Segal, O, O’Keefe SO, Wardell C, Baskett M, Pecchia A, Ferrell, K, & Ciraulo, DA . Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemporary Clinical Trials. 2014; (41):55-61.

  • Published on 5/1/2014

    DeMartini KS, Devine EG, DiClemente CC, Martin DJ, Ray LA, O'Malley SS. Predictors of pretreatment commitment to abstinence: results from the COMBINE study. J Stud Alcohol Drugs. 2014 May; 75(3):438-46. PMID: 24766756.

    Read at: PubMed
  • Published on 8/30/2013

    Ciraulo DA, Barlow DH, Gulliver SB, Farchione T, Morissette SB, Kamholz BW, Eisenmenger K, Brown B, Devine E, Brown TA, Knapp CM. The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders. Behav Res Ther. 2013 Nov; 51(11):729-35. PMID: 24055681.

    Read at: PubMed
  • Published on 7/18/2013

    Devine EG, Waters ME, Putnam M, Surprise C, O'Malley K, Richambault C, Fishman RL, Knapp CM, Patterson EH, Sarid-Segal O, Streeter C, Colanari L, Ciraulo DA. Concealment and fabrication by experienced research subjects. Clin Trials. 2013; 10(6):935-48. PMID: 23867223.

    Read at: PubMed
  • Published on 2/10/2012

    Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Tiouririne NA, Johnson B, Pettinati H, Strain EC, Devine E, Brunette MF, Kampman K, A Tompkins D, Stout R. A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients. Alcohol Clin Exp Res. 2012 Aug; 36(8):1421-30. PMID: 22324516.

    Read at: PubMed
  • Published on 1/5/2012

    Afshar M, Knapp CM, Sarid-Segal O, Devine E, Colaneri LS, Tozier L, Waters ME, Putnam MA, Ciraulo DA. The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression. Am J Drug Alcohol Abuse. 2012 Mar; 38(2):181-6. PMID: 22221171.

    Read at: PubMed
  • Published on 3/1/2010

    Knapp CM, Sarid-Segal O, Richardson MA, Colaneri LS, Afshar M, Devine E, Streeter CC, Piechniczek-Buczek J, Ciraulo DA. Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):102-5. PMID: 20337506.

    Read at: PubMed

View 6 more publications: View full profile at BUMC

View all profiles